Emicizumab

Common brands: Hemlibra, Rituxan, Tylenol Extra Strength, Tylenol Regular Strength, Altuviiio

Top reporter: Genentech, Inc.

Antifibrinolytic Agent [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]CD20-directed Cytolytic Antibody [EPC]Osmotic Laxative [EPC]
11,668
Total Reports
7,343
Serious Reports
370
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (3.17%)

Patient Demographics

Male
9,891
Female
410

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Emicizumab.

# Reaction Reports % of Total
1 HAEMORRHAGE 4,295
34.4%
2 NO ADVERSE EVENT 775
6.2%
3 HAEMARTHROSIS 774
6.2%
4 OFF LABEL USE 762
6.1%
5 FALL 624
5.0%
6 ARTHRALGIA 489
3.9%
7 CONTUSION 388
3.1%
8 EPISTAXIS 379
3.0%
9 HEAD INJURY 338
2.7%
10 PAIN 314
2.5%
11 MUSCLE HAEMORRHAGE 294
2.4%
12 WEIGHT INCREASED 223
1.8%
13 JOINT INJURY 222
1.8%
14 LIMB INJURY 218
1.7%
15 INJURY 211
1.7%
16 MOUTH HAEMORRHAGE 210
1.7%
17 DRUG INEFFECTIVE 208
1.7%
18 HEADACHE 173
1.4%
19 HAEMATOMA 169
1.4%
20 JOINT SWELLING 166
1.3%
21 INJECTION SITE PAIN 146
1.2%
22 DEATH 133
1.1%
23 WEIGHT DECREASED 132
1.1%
24 PYREXIA 126
1.0%
25 GINGIVAL BLEEDING 118
0.9%
26 LIGAMENT SPRAIN 118
0.9%
27 SWELLING 118
0.9%
28 PAIN IN EXTREMITY 116
0.9%
29 SKIN LACERATION 115
0.9%
30 TRAUMATIC HAEMORRHAGE 115
0.9%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.